Joan T. Merrill

1. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
   2012/05/02 by Michelle Petri, Ana‐Maria Orbai, Graciela S. Alarcón +60 · 45 citations
   Medicine · #Systemic Lupus Erythematosus Research #Rheumatoid Arthritis Research and Therapies #Cytomegalovirus and herpesvirus research
2. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
   2011/09/01 by Richard Furie, Michelle Petri, Omid Zamani +18 · 32 citations
   Medicine · #Systemic Lupus Erythematosus Research #Multiple Sclerosis Research Studies #Liver Diseases and Immunity
3. A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus
   2009/08/27 by Daniel J. Wallace, William Stohl, Richard A. Furie +16 · 3 citations
   Medicine · #Multiple Sclerosis Research Studies #Rheumatoid Arthritis Research and Therapies #Systemic Lupus Erythematosus Research
4. Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial
   2022/11/11 by Eric F. Morand, Marilyn C. Pike, Joan T. Merrill +10 · 1 voice · 3 citations
   Medicine · #Systemic Lupus Erythematosus Research #Rheumatoid Arthritis Research and Therapies #Cytokine Signaling Pathways and Interactions